CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.7900
0.0000 (0.00%)
At close: 3:38PM EDT
Stock chart is not supported by your current browser
Previous Close0.7900
Open0.7959
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.7800 - 0.8100
52 Week Range0.3715 - 2.5200
Volume22,046
Avg. Volume66,219
Market Cap150.209M
Beta (5Y Monthly)N/A
PE Ratio (TTM)3.04
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets
    CNW Group

    Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets

    TORONTO, July 10, 2020 /CNW/ - Three of Canopy Rivers Inc.'s ("Canopy Rivers") (TSX:RIV.TO - News) (OTC:CNPOF - News) portfolio companies have made recent announcements as they aim to introduce new or expanded choices for cannabis consumers and medical patients in Canada and the U.S. "We continue to be impressed with the ability of our portfolio companies to respond to shifting consumer demands in the cannabis space while executing on their long-term strategies," said Narbé Alexandrian, President and CEO, Canopy Rivers. The agreement follows Dynaleo's receipt of its processing licence from Health Canada and marks Pantry's first international expansion beyond the U.S. where it distributes cannabis-infused food brands for the recreational market.

  • This VC firm predicted big cannabis would shrink. What happens next?
    Yahoo Finance Canada

    This VC firm predicted big cannabis would shrink. What happens next?

    Many of the largest cannabis players were having a tough 2020 before the economic wallop of COVID-19.

  • Canopy Rivers' Portfolio Company Dynaleo Receives Health Canada Licence
    CNW Group

    Canopy Rivers' Portfolio Company Dynaleo Receives Health Canada Licence

    TORONTO, June 22, 2020 /CNW/ - Dynaleo Inc. ("Dynaleo"), the most recent addition to Canopy Rivers Inc.'s ("Canopy Rivers") (TSX:RIV.TO - News) (OTC:CNPOF - News) portfolio of disruptive cannabis companies, has received its Standard Processing Licence from Health Canada. This follows the completion and commissioning of Dynaleo's 27,000 square foot purpose-built facility, and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. "We are thrilled with the momentum at Dynaleo," said Narbé Alexandrian, President and CEO, Canopy Rivers.

  • Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors
    CNW Group

    Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors

    Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public company governance experience. The Company expects that Mr. Lee's experience at Canopy Growth, Constellation Brands, Inc. ("Constellation Brands"), and other leading consumer packaged goods and beverage companies will help strengthen its strategic execution as it continues to focus on developing a leading global cannabis portfolio.

  • Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights
    CNW Group

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

  • Canopy Rivers Announces Organizational Changes to Streamline Operations
    CNW Group

    Canopy Rivers Announces Organizational Changes to Streamline Operations

    Changes are focused on cost reduction and cash generation to enhance long-term shareholder value TORONTO , May 28, 2020 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") ...

  • Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results
    CNW Group

    Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results

    TORONTO , May 26, 2020 /CNW/ - Canopy Rivers Inc. (the " Company " or " Canopy Rivers ") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ...

  • Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results
    CNW Group

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results

    TORONTO , May 11, 2020 /CNW/ -   Canopy Rivers Inc. (the " Company " or " Canopy Rivers ") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal ...

  • Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo
    CNW Group

    Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo

    TORONTO, May 4, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced a C$2 million investment in Dynaleo Inc. ("Dynaleo"), an Edmonton-based company focused on white-label manufacturing edible cannabis gummies for the Canadian market. Through this investment in what the Company anticipates may become a leading industrial scale Canadian gummies manufacturer, Canopy Rivers believes it is capitalizing on a significant opportunity in what is currently an underserved and underdeveloped segment of the cannabis market. Once Dynaleo receives the required licencing from Health Canada, it expects to begin operating its 27,000 sq. ft. purpose-built facility with the goal of producing enough gummies to take a sizable bite out of the projected edibles market.

  • Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million
    CNW Group

    Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million

    TORONTO , April 16, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario , amended its syndicated credit facility ("Credit Facility") with the Bank of Montreal ("BMO"), as the agent and lead lender, and the Canadian Imperial Bank of Commerce and Concentra Bank (together with BMO, the "Lenders"). The amended terms of the Credit Facility (the "Amendment") provides PharmHouse with an additional $10 million of secured debt financing, representing an increase to the Credit Facility that was initially announced in January 2019 .

  • Canopy Rivers Announces Launch of Normal Course Issuer Bid
    CNW Group

    Canopy Rivers Announces Launch of Normal Course Issuer Bid

    TORONTO , March 31, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.TO) (CNPOF), a venture capital firm specializing in cannabis, announces that the Toronto Stock Exchange ("TSX") has accepted the notice of Canopy Rivers' intention to commence a normal course issuer bid (the "NCIB"). The NCIB reflects management's position that the current share price does not reflect the Company's underlying value and future prospects.

  • Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth
    CNW Group

    Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth

    Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth

  • Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment
    CNW Group

    Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment

    TORONTO, March 2, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario, received a licence amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. PharmHouse plans to immediately ramp up production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. PharmHouse has committed 50% of its 2020 output pursuant to these agreements, and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand. "The receipt of our licence amendment represents a large milestone for PharmHouse,"  said Tony Abbas, General Manager, PharmHouse.

  • Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence
    CNW Group

    Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence

    Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence

  • Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
    CNW Group

    Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

    Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

  • Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment
    CNW Group

    Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment

    TORONTO, Feb. 7, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing (the "Offering"). Each Unit is comprised of one common share in the capital of JWC (each a "Common Share") and one-half of one Common Share purchase warrant (each full warrant, a "Warrant").

  • Rivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint
    CNW Group

    Rivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint

    TORONTO, Feb. 6, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' President & CEO, one brand's retail launch in Canada, and a founder and portfolio company receiving awards for their accomplishments. Other Canopy Rivers portfolio companies hit the milestones required to help further expand and build out their facilities.

  • TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
    CNW Group

    TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies

    TORONTO , Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.

  • Canopy Rivers Amends Terms of Loan to TerrAscend Canada
    CNW Group

    Canopy Rivers Amends Terms of Loan to TerrAscend Canada

    TORONTO, Feb. 5, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that as of February 4, 2020 Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of CRI, has amended the terms of its recent US$10 million loan (the "Loan") to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly‑owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The Loan, announced October 2, 2019, included the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend allowing for the purchase of common shares of TerrAscend (the "Common Shares") (the "Original Warrants") with an exercise price of C$6.49.

  • Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
    CNW Group

    Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO , Jan. 24, 2020 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its third ...

  • Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations

    TORONTO , Jan. 17, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis operations. Two portfolio companies are evaluating opportunities to expand their retail footprint in Canada , while another will remember 2019 as the year it grew its retail presence across the U.S., Canada , and Europe . Another Canopy Rivers portfolio company is taking steps to build out its U.S. operations, as more states look to legalize medical or recreational cannabis.

  • 115 cannabis drink companies are taking aim at booze and soda
    Yahoo Finance Canada

    115 cannabis drink companies are taking aim at booze and soda

    Beer, wine and spirit giants and small startups alike are betting on cannabis beverages disrupting the drinks market with products that can soothe sore muscles after a workout, or deliver a hangover-free buzz. 

  • Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
    CNW Group

    Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

    TORONTO, Jan. 8, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medical cannabis. While BioLumic's approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%, this approval marks the first time the company's UV light technology will be used on cannabis.

  • Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note

    TORONTO, Dec. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies made several announcements that demonstrate the portfolio's continued growth heading into 2020. Among others, this includes new features from a business intelligence and analytics software platform, a licensed producer responding to consumer demands for high-THC products with the launch of four new cannabis strains, and a portfolio company expanding its retail footprint.

  • Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board
    CNW Group

    Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board

    Advisory board role marks star-backed venture firm's first exposure to Canadian cannabis sector TORONTO , Nov. 26, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers ") (TSX: RIV, OTC: CNPOF), ...